 |
 |
 |
 |
|
 |
 |
Alvir JMJ, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis: incidence and risk
factors in the United States. N Engl J Med 1993; 329:162.
Brier AF, Malhotra AK, Su T-P, et al. Clozapine and risperidone in chronic schizophrenia: effects on
symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry 1999; 156:294.
Kane J, Honigfeld G, Singer J, et al. The Clozaril Collaborative Study Group: clozapine for the
treatment-resistant schizophrenic. A double-blind comparison vs. chlorpromazine/benztropine. Arch Gen
Psychiatry 1988; 45:769.
Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode
psychosis. Am J Psychiatry 1999; 156:79.
Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. Arch Gen
Psychiatry 1997; 54:549.
Wahlbeck K, Cheine M, Essali A, et al. Evidence of clozapine's effectiveness in schizophrenia: a
systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999; 156:990.
Wirshing DA, Marshall BD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J
Psychiatry 1999; 156:1374.
Антипсихотики-депо
Carpenter WT Jr, Buchanan RW, Kirkpatrick B, et al. Comparative effectiveness of fluphenazine
decanoate injections every 2 weeks versus every 6 weeks. Am J Psychiatry 1999; 156:412.
Побочные эффекты и токсичность
Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research
synthesis. Am J Psychiatry 1999; 156:1686.
Arana GW, Goff D, Baldessarini RJ, et al. The effect of anticholinergic prophylaxis on neuroleptic-
induced dystonia. Am J Psychiatry 1988; 145:993.
Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57(suppl 11 ):40.
Chouinard G, Annable L, Ross-Choiunard A, et al. A 5-year prospective longitudinal study of tardive
dyskinesia: factors predicting appearance of new cases. J Clin Psychopharmacol 1988; 8(suppl):21.
Fleischhacker WW, Roth SD, Kane JM. The pharmacologic treatment of neuroleptic-induced akathisia.
J
Clin Psychopharmacol 1990; 10:12.
Fulop G, Phillips RA, Shapiro AK, et al. ECG changes during haloperidol and pimozide treatment of
Tourette's disorder. Am J Psychiatry 1987; 144:673.
Gardos G, Casey DE, Cole JO, et al. Ten-year outcome of tardive dyskinesia. Am J
Psychiatry 1994;
151:836.
Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J
Psychiatry 1989; 146:717.
Rosenberg MR, Green M. Neuroleptic malignant syndrome: review of response to therapy. Arch Intern
Med 1989; 149:1927.
Лекарственные взаимодействия
Ciraulo D, Shader RI, Greenblatt DJ, et al. Drug interactions in psychiatry. Baltimore: Williams &
Wilkins, 1995.
Применение у пожилых
Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared
with haloperidol in older patients. J Am Geriatr Soc 1999; 47:7l6.
Применение при беременности
Cohen LS, Altshuler LL. Pharmacologic management of psychiatric illness during pregnancy and the
postpartum period. Psychiatr Clin North Am 1997; 21:60.
